Top

Published in:

Open Access 01-12-2015 | Review

WSES guidelines for management of Clostridium difficile infection in surgical patients

Authors: Massimo Sartelli, Mark A. Malangoni, Fikri M. Abu-Zidan, Ewen A. Griffiths, Stefano Di Bella, Lynne V. McFarland, Ian Eltringham, Vishal G. Shelat, George C. Velmahos, Ciarán P. Kelly, Sahil Khanna, Zaid M. Abdelsattar, Layan Alrahmani, Luca Ansaloni, Goran Augustin, Miklosh Bala, Frédéric Barbut, Offir Ben-Ishay, Aneel Bhangu, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Laura A. Canterbury, Fausto Catena, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria Elena Cocuz, Raul Coimbra, Charles H. Cook, Yunfeng Cui, Jacek Czepiel, Koray Das, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina Magdalena Dumitru, Catherine Eckert, Christian Eckmann, Edward H. Eiland, Mushira Abdulaziz Enani, Mario Faro, Paula Ferrada, Joseph Derek Forrester, Gustavo P. Fraga, Jean Louis Frossard, Rita Galeiras, Wagih Ghnnam, Carlos Augusto Gomes, Venkata Gorrepati, Mohamed Hassan Ahmed, Torsten Herzog, Felicia Humphrey, Jae Il Kim, Arda Isik, Rao Ivatury, Yeong Yeh Lee, Paul Juang, Luis Furuya-Kanamori, Aleksandar Karamarkovic, Peter K Kim, Yoram Kluger, Wen Chien Ko, Francis D. LaBarbera, Jae Gil Lee, Ari Leppaniemi, Varut Lohsiriwat, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick Alan Moore, Carl Erik Nord, Carlos A. Ordoñez, Gerson Alves Pereira Júnior, Nicola Petrosillo, Francisco Portela, Basant K. Puri, Arnab Ray, Mansoor Raza, Miran Rems, Boris E. Sakakushev, Gabriele Sganga, Patrizia Spigaglia, David B. Stewart, Pierre Tattevin, Jean Francois Timsit, Kathleen B. To, Cristian Tranà, Waldemar Uhl, Libor Urbánek, Harry van Goor, Angela Vassallo, Jean Ralph Zahar, Emanuele Caproli, Pierluigi Viale

Published in: World Journal of Emergency Surgery | Issue 1/2015

Abstract

In the last two decades there have been dramatic changes in the epidemiology of Clostridium difficile infection (CDI), with increases in incidence and severity of disease in many countries worldwide. The incidence of CDI has also increased in surgical patients. Optimization of management of C difficile, has therefore become increasingly urgent. An international multidisciplinary panel of experts prepared evidenced-based World Society of Emergency Surgery (WSES) guidelines for management of CDI in surgical patients.

Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis. 2010;10:395–404.PubMed

Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis. 2012;55:65–70.

Goudarzi M, Seyedjavadi SS, Goudarzi H, Mehdizadeh Aghdam E, Nazeri S. Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica. 2014;2014:916826.PubMedCentralPubMed

To KB, Napolitano LM. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies. Surg Infect. 2014;15:490–502.

Eckmann C, Wasserman M, Latif F, Roberts G, Beriot-Mathiot A. Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries. Eur J Health Econ. 2013;14(5):835–46.PubMed

Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98.PubMed

Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20 Suppl 2:1–26.PubMed

Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect. 2007;8:557–66.

Halabi WJ, Nguyen VQ, Carmichael JC, Pigazzi A, Stamos MJ, Mills S. Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. J Am Coll Surg. 2013;217:802–12.PubMed

10.

Herzog, T, Deleites C, Belyaev O, Chromik AM, Uhl W. Clostridium difficile in visceral surgery, Chirurg. 2014; Nov 30. [Epub ahead of print].

11.

Abdelsattar ZM, Krapohl G, Alrahmani L, Banerjee M, Krell RW, Wong SL, et al. Postoperative Burden of Hospital-Acquired Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2015;36(1):40–6.PubMed

12.

Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest. 2006;129:174–81.PubMed

13.

Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009;64:1109–16.PubMed

14.

Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology. 1981;81:5–9.PubMed

15.

Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis. 1994;18:181–7.PubMed

16.

Walker KJ, Gilliland SS, Vance-Bryan K, Moody JA, Larsson AJ, Rotschafer JC, et al. Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors. J Am Geriatr Soc. 1993;41:940–6.PubMed

17.

Cheng AC, Ferguson JK, Richards MJ, Robson JM, Gilbert GL, McGregor A, et al. Australasian Society for Infections Diseases. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust. 2011;194:353–8.PubMed

18.

McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium Difficile infection. N Engl J Med. 1989;320:204–10.PubMed

19.

Shaughnessy MK, Micielli RL, Depestel DD, Arndt J, Strachan CL, Welch KB, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32:201–6.PubMed

20.

Pruitt RN, Lacy DB. Toward a structural understanding of Clostridium difficile toxins A and B. Front Cell Infect Microbiol. 2012;2:28.PubMedCentralPubMed

21.

Jank T, Giesemann T, Aktories K. Rho-glucosylating Clostridium difficile Toxins A and B: new insights into structure and function. Glycobiology. 2007;17:15R–22.PubMed

22.

Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature. 2010;467:711–3.PubMed

23.

Carter GP, Rood JI, Lyras D. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 2012;20:21–9.PubMed

24.

Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis. 2014;209(1):83–6.PubMedCentralPubMed

25.

Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079–84.PubMed

26.

Eckert C, Coignard B, Hebert M, Tarnaud C, Tessier C, Lemire A, et al. ICD-Raisin Working Group. Clinical and microbiological features of Clostridium difficile infections in France: the ICD-RAISIN 2009 national survey. Med Mal Infect. 2013;43:67–74.PubMed

27.

Barbut F, Mastrantonio P, Delmée M, Brazier J, Kuijper E, Poxton I. European Study Group on Clostridium difficile (ESGCD). Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect. 2007;13:1048–57.PubMed

28.

Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377:63–73.PubMed

29.

De Rosa FG, Cavallerio P, Corcione S, Parlato C, Fossati L, Serra R, et al. Molecular Characterization of Toxigenic Clostridium difficile in a Northern Italian Hospital. Curr Microbiol. 2015;70(2):154–5.PubMed

30.

Geric B, Johnson S, Gerding DN, Grabnar M, Rupnik M. Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol. 2003;41:5227–32.PubMedCentralPubMed

31.

Barth H. Uptake of binary actin ADP-ribosylating toxins. Rev Physiol Biochem Pharmacol. 2004;152:165–82.PubMed

32.

Bacci S, Mølbak K, Kjeldsen MK, Olsen KE. Binary toxin and death after clostridium difficile infection. Emerg Infect Dis. 2011;17:976–82.PubMedCentralPubMed

33.

Sundriyal A, Roberts AK, Ling R, McGlashan J, Shone CC, Acharya KR. Expression, purification and cell cytotoxicity of actin-modifying binary toxin from Clostridium difficile. Protein Expr Purif. 2010;74:42–8.PubMed

34.

Huber CA, Foster NF, Riley TV, Paterson DL. Challenges for standardization of Clostridium difficile typing methods. J Clin Microbiol. 2013;51:2810–4.PubMedCentralPubMed

35.

Clements AC, Magalhaes RJ, Tatem AJ, Paterson DL, Riley TV. C. difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis. 2010;10:395–404.PubMed

36.

Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46:12–8.

37.

Lawrence J. Contemporary management of Clostridium difficile associated-disease. Gastroenterol Endosc News Speed. 2007;5:35–40.

38.

Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693–703.PubMed

39.

McFarland LV. Renewed interest in a difficult disease: Clostridium difficile infections--epidemiology and current treatment strategies. Curr Opin Gastroenterol. 2009;25:24–35.PubMed

40.

Vecchio AL, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol. 2012;28:1–9.PubMed

41.

Furuya-Kanamori L, Stone JC, Clark J, McKenzie SJ, Yakob L, Paterson DL, et al. Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol. 2015;36(2):132–41.PubMed

42.

Garey KW, Jiang ZD, Ghantoji S, Tam VH, Arora V, Dupont HL. A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. Clin Infect Dis. 2010;51(12):1406–10.PubMed

43.

Sanders NL, Bollinger RR, Lee R, Thomas S, Parker W. Appendectomy and Clostridium difficile colitis: relationships revealed by clinical observations and immunology. World J Gastroenterol. 2013;19(34):5607–14.PubMedCentralPubMed

44.

Seretis C, Seretis F, Goonetilleke K. Appendicectomy and clostridium difficile infection: is there a link? J Clin Med Res. 2014;6(4):239–41.PubMedCentralPubMed

45.

Clanton J, Subichin M, Drolshagen K, Daley T, Firstenberg MS. Fulminant Clostridium difficile infection: An association with prior appendectomy? World J Gastrointest Surg. 2013;5(8):233–8.PubMedCentralPubMed

46.

Yong FA, Alvarado AM, Wang H, Tsai J, Estes NC. Appendectomy: a risk factor for colectomy in patients with Clostridium difficile. Am J Surg. 2014;17.

47.

Khanna S, Baddour LM, Dibaise JK, Pardi DS. Appendectomy is not associated with adverse outcomes in clostridium difficile infection: a population-based study. Am J Gastroenterol. 2013;108(4):626–7.PubMed

48.

Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A, et al. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe. 2014;30:65–9.PubMed

49.

Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O’Connor L, et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 2012;9(2), e1001172.PubMedCentralPubMed

50.

Theriot CM, Young VB. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes. 2014;5(1):86–95.PubMedCentralPubMed

51.

Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13(5):321–35.PubMed

52.

Pérez-Cobas AE, Artacho A, Ott SJ, Moya A, Gosalbes MJ, Latorre A. Structural and functional changes in the gut microbiota associated to Clostridium difficile infection. Front Microbiol. 2014;5:335.PubMedCentralPubMed

53.

Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685–90.PubMedCentralPubMed

54.

Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67:742–8.PubMed

55.

Kazakova SV, Ware K, Baughman B, Bilukha O, Paradis A, Sears S, et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med. 2006;166:2518–24.PubMed

56.

Muto CA, Pokrywka M, Shutt K, Mendelshon AB, Nouri K, Posey K, et al. A large outbreak of Clostridium difficile–associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273–80.PubMed

57.

Loo VG, Poirier L, Miller MA, Oughton M, Libman MB, Michaud S, et al. A predominately clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9.PubMed

58.

Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254–60.PubMed

59.

Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45:1543–9.PubMed

60.

Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46:19–31.

61.

McCusker ME, Harris AD, Perencevich E, Roghmann M. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis. 2003;9:730–3.PubMedCentralPubMed

62.

Gerding DN, Olson MM, Peterson LR, Teasley LR, Gebhard RL, Schwartz ML, et al. Clostridium difficile-associated diarrhea and colitis in adults. Arch Intern Med. 1986;146:95–100.PubMed

63.

Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol. 1990;11:283–90.PubMed

64.

Iv EC, Iii EC, Johnson DA. Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther. 2014;5:1–26.PubMedCentralPubMed

65.

Privitera G, Scarpellini P, Ortisi G, Nicastro G, Nicolin R, De Lalla F. Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother. 1991;35:208–10.PubMedCentralPubMed

66.

Yee J, Dixon CM, McLean AP, Meakins JL. Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics. Arch Surg. 1991;126:241–6.PubMed

67.

Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54:243–5.PubMed

68.

Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies. CMAJ. 2004;171:33–8.PubMedCentralPubMed

69.

Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107(7):1011–9.PubMed

70.

Shah S, Lewis A, Leopold D, Dunstan F, Woodhouse K. Gastric acid suppression does not promote clostridial diarrhoea in the elderly. QJM. 2000;93:175–81.PubMed

71.

Kent KC, Rubin MS, Wroblewski L, Hanff PA, Silen W. The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Ann Surg. 1998;227:296–301.PubMedCentralPubMed

72.

McDonald LC, Killgore GE, Thompson A, Owens Jr RC, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Eng Jour Med. 2005;353:2433–41.

73.

Rodrigues MA, Brady RR, Rodrigues J, Graham C, Gibb AP. Clostridium difficile infection in general surgery patients; identification of high-risk populations. Int J Surg. 2010;8:368–72.PubMed

74.

Kim MJ, Kim BS, Kwon JW, Ahn SE, Lee SS, Park HC, et al. Risk factors for the development of Clostridium difficile colitis in a surgical ward. J Korean Surg Soc. 2012;83:14–20.PubMedCentralPubMed

75.

Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S, Fushimi K. The burden of Clostridium difficile-associated disease following digestive tract surgery in Japan. J Hosp Infect. 2012;82:175–80.PubMed

76.

Wren SM, Ahmed N, Jamal A, Safadi BY. Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch Surg. 2005;140:752–6.PubMed

77.

Yeom CH, Cho MM, Baek SK, Bae OS. Risk Factors for the Development of Clostridium difficile-associated Colitis after Colorectal Cancer Surgery. J Korean Soc Coloproctol. 2010;26:329–33.PubMedCentralPubMed

78.

Damle RN, Cherng NB, Flahive JM, Davids JS, Maykel JA, Sturrock PR, et al. Clostridium difficile infection after colorectal surgery: a rare but costly complication. J Gastrointest Surg. 2014;18:1804–11.PubMed

79.

Lumpkins K, Bochicchio GV, Joshi M, Gens R, Bochicchio K, Conway A, et al. Clostridium difficile infection in critically injured trauma patients. Surg Infect. 2008;9:497–501.

80.

Egorova NN, Siracuse JJ, McKinsey JF, Nowygrod R. Trend, risk factors and costs of Clostridium Difficile infections in vascular surgery. Ann Vasc Surg. 2015;S0890-5096(15):00015–1.

81.

Navaneethan U, Mukewar S, Venkatesh PG, Lopez R, Shen B, Nitzan O, et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis. 2012;6:330–6.PubMed

82.

Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2010;55:415–20.PubMed

83.

Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345–51.PubMed

84.

Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205–10.PubMed

85.

Clayton EM, Rea MC, Shanahan F, Quigley EM, Kiely B, Hill C, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol. 2009;104:1162–9.PubMed

86.

Schneeweiss S, Korzenik J, Solomon DH, Canning C, Lee J, Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009;30:253–64.PubMed

87.

Kariv R, Navaneethan U, Venkatesh PG, Lopez R, Shen B. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5:34–40.PubMed

88.

Absah I, Faubion WA. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn’s colitis: a case series. Inflamm Bowel Dis. 2012;18:1488–92.PubMed

89.

Rodemann JF, Dubberke ER, Reske KA, da Seo H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–44.PubMed

90.

Tsironi E, Irving PM, Feakins RM, Rampton DS. “Diversion” colitis caused by Clostridium difficile infection: report of a case. Dis Colon Rectum. 2006;49:1074–7.PubMed

91.

Li Y, Qian J, Queener E, Shen B. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. Inflamm Bowel Dis. 2013;19:397–403.PubMed

92.

Ben-Horin S, Margalit M, Bossuyt P, Maul J, Shapira Y, Bojic D, et al. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. J Crohns Colitis. 2010;4:194–8.PubMed

93.

Yanai H, Nguyen GC, Yun L, Lebwohl O, Navaneethan U, Stone CD, et al. Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: antibiotics alone or combined antibiotics/immunomodulators? Inflamm Bowel Dis. 2011;17:1540–6.PubMed

94.

Albright JB, Bonatti H, Mendez J, Kramer D, Stauffer J, Hinder R, et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int. 2007;20(10):856–66.PubMed

95.

Chopra T, Alangaden GJ, Chandrasekar P. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther. 2010;8(10):1113–9.PubMed

96.

Rodríguez Garzotto A, Mérida García A, Muñoz Unceta N, Galera Lopez MM,Orellana-Miguel MA, Díaz-García CV, et al. Risk factors associated with Clostridium difficile infection in adult oncology patients. Support Care Cancer. 2014 Nov 20. [Epub ahead of print]

97.

Haines CF, Moore RD, Bartlett JG, Sears CL, Cosgrove SE, Carroll K, et al. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS. 2013;27(17):2799–807.PubMed

98.

Collini PJ, Kuijper E, Dockrell DH. Clostridium difficile infection in patients with HIV/AIDS. Curr HIV/AIDS Rep. 2013;10(3):273–82.PubMed

99.

Zhu Y, Wang L, Feng S, Wang S, Zheng C, Wang J, et al. Risk factors for Clostridium difficile-associated diarrhea among cancer patients. Zhonghua Zhong Liu Za Zhi. 2014;36(10):773–7.PubMed

100.

Gupta A, Khanna S. Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist. 2014;7:63–72.PubMedCentralPubMed

101.

Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM. Outcomes in community-acquired Clostridium difficile infection. Aliment Pharmacol Ther. 2012;35(5):613–8.PubMedCentralPubMed

102.

Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008;70:298–304.PubMed

103.

Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, et al. Infections in Oxfordshire Research Database. Predictors of first recurrence of Clostridium difficile infection:implications for initial management. Clin Infect Dis. 2012;55:77–87.

104.

Zilberberg MD, Reske K, Olsen M, Yan Y, Dubberke ER. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis. 2014;14:306.PubMedCentralPubMed

105.

Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Hernandez AV, et al. Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis. Infect Control Hosp Epidemiol. 2015 Jan 28:1–9. [Epub ahead of print]

106.

Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis. 2012;55:154–61.

107.

McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis. 2007;45:1141–51.PubMed

108.

Jaber MR, Olafsson S, Fung WL, Reeves ME. Clinical review of the management of fulminant clostridium difficile infection. Am J Gastroenterol. 2008;103(12):3195–203.PubMed

109.

Kazanowski M, Smolarek S, Kinnarney F, Grzebieniak Z. Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities - a systematic review. Tech Coloproctol. 2014;18:223–32.PubMedCentralPubMed

110.

Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect. 2011;79:359–63.PubMed

111.

Hu MY, Katchar K, Kyne L, Maroo S, Tummala S, Dreisbach V, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology. 2009;136:1206–14.PubMed

112.

Voelker R. Increased Clostridium difficile virulence demands new treatment approach. JAMA. 2010;26:2017–9.

113.

Bauer MP, Hensgens MPM, Miller MA, Gerding DN, Wilcox MH, Dale AP, et al. Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. Clin Infect Dis. 2012;55:149–53.

114.

Abou Chakra CN, Pepin J, Valiquette L. Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS ONE. 2012;7, e30258.PubMedCentralPubMed

115.

Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013;13:148.PubMedCentralPubMed

116.

Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.PubMed

117.

Flegel W, Muller F, Daubener W, Fisher HG, Hadding U, Northoff H. Cytokine response by human monocytes to Clostridium difficile toxin a and toxin B. Infect Immun. 1991;59:3659–66.PubMedCentralPubMed

118.

Castagliuolo I, Keates AC, Wang CC, Pasha A, Valenick L, Kelly CP, et al. Clostridium difficile toxin a stimulates macrophage- inflammatory protein-2 production in rat intestinal epithelial cells. J Immunol. 1998;160:6039–45.PubMed

119.

Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235:363–72.PubMedCentralPubMed

120.

Adams SD, Mercer DW. Fulminant Clostridium difficile colitis. Curr Opin Crit Care. 2007;13:450–5.PubMed

121.

Malnick SD, Zimhony O. Treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother. 2002;36:1767–75.PubMed

122.

McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002;97:1769–75.PubMed

123.

Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, et al. Predictors of first recurrence of Clostridium difficile infection: Implications for initial management. Clin Infect Dis. 2012;55 Suppl 2:S77–87.PubMedCentralPubMed

124.

Hu MY, Katchar K, Kyne L, Maroo S, Tummala S, Dreisbach V, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostiridium difficle infection. Gastroenterology. 2009;136:1206–14.PubMed

125.

Kelly JP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 2012;18 Suppl 6:21–7.PubMed

126.

Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME. Recurrent Clostridium difficile diarrhea: Characteristics of and the risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis. 1997;24(3):324–33.PubMed

127.

Samie AA, Traub M, Bachmann K, Kopischke K, Theilmann L. Risk factors for recurrence of Clostridium difficile-associated diarrhea. Hepatogastroenterology. 2013;60(126):1351–4.PubMed

128.

LaBarbera FD, Nikiforov I, Parvathenani A, Pramil V, Gorrepati S. A prediction model for Clostridium difficile recurrence. J Community Hosp Intern Med Perspect. 2015;5(1):26033.PubMed

129.

Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol. 2009;15:1554–80.PubMedCentralPubMed

130.

Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol. 2013;34:588–96.PubMed

131.

Campbell R, Dean B, Nathanson B, Haidar T, Strauss M, Thomas S. Length of stay and hospital costs among high-risk patients with hospital-origin Clostridium difficile-associated diarrhea. J Med Econ. 2013;16:440–8.PubMed

132.

Magalini S, Pepe G, Panunzi S, Spada PL, De Gaetano A, Gui D. An economic evaluation of Clostridium difficile infection management in an Italian hospital environment. Eur Rev Med Pharmacol Sci. 2012;16(15):2136–41.PubMed

133.

Skovrlj B, Guzman JZ, Silvestre J, Al Maaieh M, Qureshi SA. Clostridium difficile colitis in patients undergoing lumbar spine surgery. Spine. 2014;39:1167–73.

134.

Mittal C, Hassan S, Arshad S, Jeepalyam S, Bruni S, Miceli M, et al. Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes. Am J Transplant. 2014;14:1901–7.PubMed

135.

Lee DY, Chung EL, Guend H, Whelan RL, Wedderburn RV, Rose KM. Predictors of mortality after emergency colectomy for Clostridium difficile colitis: an analysis of ACS-NSQIP. Ann Surg. 2014;259:148–56.PubMed

136.

Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, et al. Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management? Clin Microbiol Infect. 2014;20(2):136–44.PubMed

137.

Kundrapu S, Sunkesula VC, Jury LA, Sethi AK, Donskey CJ. Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection. Clin Infect Dis. 2012;55(11):1527–30.PubMed

138.

Carroll KC. Tests for the diagnosis of Clostridium difficile infection: the next generation. Anaerobe. 2011;17:170–4.PubMed

139.

Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342:390–7.PubMed

140.

Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis. 2008;8:777–84.PubMed

141.

Brecher SM, Novak-Weekley SM, Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis. 2013;57:1175–81.PubMed

142.

Lyerly DM, Barroso LA, Wilkins TD. Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol. 1991;29:2639–42.PubMedCentralPubMed

143.

Schmidt ML, Gilligan PH. Clostridium difficile testing algorithms: what is practical and feasible? Anaerobe. 2009;15:270–3.PubMed

144.

Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis. 2013;13:936–45.PubMedCentralPubMed

145.

Ros PR, Buetow PC, Pantograg-Brown L, Forsmark CE, Sobin LH. Pseudomembranous colitis. Radiology. 1996;198:1–9.PubMed

146.

Merine DS, Fishman EK, Jones B. Pseudomembranous colitis: CT evaluation. J Comput Assist Tomogr. 1987;2:1017–20.

147.

Fishman EK, Kavuru M, Jones B, Kuhlman JE, Merine DS, Lillimoe KD, et al. Pseudomembranous colitis: CT evaluation of 26 cases. Radiology. 1991;180:57–60.PubMed

148.

Boland GW, Lee MJ, Cats AM, Gaa JA, Saini S, Mueller PR. Antibiotic-induced diarrhea: specificity of abdominal CT for the diagnosis of Clostridium difficile disease. Radiology. 1994;191:103–6.PubMed

149.

Wang MF, Ding Z, Zhao J, Jiang CQ, Liu ZS, Qian Q. Current role of surgery for the treatment of fulminant Clostridium difficile colitis. Chin Med J (Engl). 2013;126:949–56.

150.

Kirkpatrick ID, Greenberg HM. Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy? Am J Roentgenol. 2001;176:635–9.

151.

Abu-Zidan FM. Point-of-care ultrasound in critically ill patients: Where do we stand? J Emerg Trauma Shock. 2012;5:70–1.PubMedCentralPubMed

152.

O’Malley ME, Wilson SR. US of gastrointestinal tract abnormalities with CT correlation. Radiographics. 2003;23:59–72.PubMed

153.

Downey DB, Wilson SR. Pseudomembranous colitis: sonographic features. Radiology. 1991;180:61–4.PubMed

154.

Ramachandran I, Sinha R, Rodgers P. Pseudomembranous colitis revisited: spectrum of imaging findings. Clin Radiol. 2006;61:535–44.PubMed

155.

Razzaq R, Sukumar SA. Ultrasound diagnosis of clinically undetected Clostridium difficile toxin colitis. Clin Radiol. 2006;61:446–52.PubMed

156.

Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol. 2009;15:1554–158.PubMedCentralPubMed

157.

Johal SS, Hammond J, Solomon K, James PD, Mahida YR. Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut. 2004;53:673–7.PubMedCentralPubMed

158.

Kyne L, Merry C, O’Connell B, Kelly A, Keane C, O’Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing. 1999;28:107–13.PubMed

159.

Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398–408.PubMed

160.

Bartlett JG. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46:1489–92.PubMed

161.

Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, et al. Prospective randomised trial of metronidazole vs vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet. 1983;2:1043–6.PubMed

162.

Fekety R, Silva J, Buggy B, Deery HG. Treatment of antibiotic-associated colitis with vancomycin. J Antimicrob Chemother. 1984;14:97–102.PubMed

163.

Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang T. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology. 1980;78:431–4.PubMed

164.

Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422–31.PubMed

165.

Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012;12:281–9.PubMed

166.

Gerber M, Ackermann G. OPT-80. A macrocyclic antimicrobial agent for the treatment of clostridium difficile infections: a review. Exp Opin Investig Drugs. 2008;17:547–53.

167.

Nelson RL. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2011;7(9):CD004610.

168.

Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–7.PubMed

169.

Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ. Comparison of clinical and microbiological response to treatment of Clostridium difficile -associated disease with metronidazole and vancomycin. Clin Infect Dis. 2008;47:56–62.PubMed

170.

Johnson S, Louie TJ, Gerding DN, Cornely OA, Chasan-Taber S, Fitts D, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345–54.PubMed

171.

Kim PK, Huh HC, Cohen HW, Feinberg EJ, Ahmad S, Coyle C, et al. Intracolonic vancomycin for severe Clostridium difficile colitis. Surg Infect. 2013;14:532–9.

172.

Eiland 3rd EH, Sawyer AJ, Massie NL. Fidaxomicin Use and Clinical Outcomes for Clostridium difficile-Associated Diarrhea. Infect Dis Clin Pract (Baltim Md). 2015;23(1):32–5.

173.

Vargo CA, Bauer KA, Mangino JE, Johnston JE, Goff DA. An antimicrobial stewardship program’s real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series. Pharmacotherapy. 2014;34(9):901–9.PubMed

174.

Herpers BL, Vlaminckx B, Burkhardt O, Blom H, Biemond-Moeniralam HS, Hornef M, et al. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection. Clin Infect Dis. 2009;48:1732–5.PubMed

175.

El-Herte RI, Baban TA, Kanj SS. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: A case report and review of the literature. Scan J Infect Dis. 2012;44:228–30.

176.

Musher DM, Logan N, Mehendiratta V, Melgarejo NA, Garud S, Hamill RJ. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother. 2007;59(4):705–10.PubMed

177.

Girotra M, Kumar V, Khan JM, Damisse P, Abraham RR, Aggarwal V, et al. Clinical predictors of fulminant colitis in patients with Clostridium difficile infection. Saudi J Gastroenterol. 2012;18:133–9.PubMedCentralPubMed

178.

Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012;87:1106–17.PubMedCentralPubMed

179.

Clanton J, Fawley R, Haller N, Daley T, Porter J, Paranjape C, et al. Patience is a virtue: an argument for delayed surgical intervention in fulminant Clostridium difficile colitis. Am Surg. 2014;80(6):614–9.PubMed

180.

Carchman EH, Peitzman AB, Simmons RL, Zuckerbraun BS. The role of acute care surgery in the treatment of severe, complicated Clostridium difficile-associated disease. J Trauma Acute Care Surg. 2012;73:789–800.PubMed

181.

Stewart DB, Hollenbeak CS, Wilson MZ. Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review. Colorectal Dis. 2013;15:798–804.PubMed

182.

Ali SO, Welch JP, Dring RJ. Early surgical intervention for fulminant pseudomembranous colitis. Am Surg. 2008;74:20–6.PubMed

183.

Chan S, Kelly M, Helme S, Gossage J, Modarai B, Forshaw M. Outcomes following colectomy for Clostridium difficile colitis. Int J Surg. 2009;7:78–81.PubMed

184.

Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg. 2008;196:384–8.PubMed

185.

Osman KA, Ahmed MH, Hamad MA, Mathur D. Emergency colectomy for fulminant Clostri- dium difficile colitis: Striking the right balance. Scan J Gastroenterol. 2011;46:1222–7.

186.

Seder CW, Villalba Jr MR, Robbins J, Ivascu FA, Carpenter CF, Dietrich M, et al. Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: An 8-year experience. Am J of Surg. 2009;197:302–7.

187.

van der Wilden GM, Chang Y, Cropano C, Subramanian M, Schipper IB, Yeh DD, et al. Fulminant Clostridium difficile colitis: prospective development of a risk scoring system. J Trauma Acute Care Surg. 2014;76:424–30.PubMed

188.

Ferrada P, Velopulos CG, Sultan S, Haut ER, Johnson E, Praba-Egge A, et al. Timing and type of surgical treatment of Clostridium difficile-associated disease: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2014;76:1484–93.PubMed

189.

Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144:433–9.PubMed

190.

191.

Bhangu A, Nepogodiev D, Gupta A, Torrance A, Singh P, West Midlands Research Collaborative. Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis. Br J Surg. 2012;99:1501–13.PubMed

192.

Lamontagne F, Labbé AC, Haeck O, Lesur O, Lalancette M, Patino C, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245:267–72.PubMedCentralPubMed

193.

Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254:423–37.PubMed

194.

Olivas AD, Umanskiy K, Zuckerbraun B, Alverdy JC. Avoiding colectomy during surgical management of fulminant Clostridium difficile colitis. Surg Infect. 2010;11:299–305.

195.

196.

O’Horo JC, Jindai K, Kunzer B, Safdar N. Treatment of recurrent Clostridium difficile infection: a systematic review. Infection. 2014;42:43–59.PubMedCentralPubMed

197.

Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis. 2012;55:154–61.

198.

McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002;97(7):1769–75.PubMed

199.

McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913–8.PubMed

200.

Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31:1012–7.PubMed

201.

McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101:812–22.PubMed

202.

Johnson S, Maziade PJ, McFarland LV, Trick W, Donskey C, Currie B, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis. 2012;16(11):e786–92.PubMed

203.

Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044–9.PubMedCentralPubMed

204.

Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012;87:1106–17.PubMedCentralPubMed

205.

Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.PubMed

206.

Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014;48(8):693–702.PubMed

207.

Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(4):500–8.PubMed

208.

van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–15.PubMed

209.

Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):1772–8.PubMed

210.

Di Bella S, Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: Focus on immunocompromised patients. J Infect Chemother. 2015;21(4):230–7.PubMed

211.

Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109:1065–71.PubMed

212.

Abourgergi MS, Kwon JH. Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review. Dig Dis Sci. 2011;56:19–26.

213.

Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362:197–205.PubMed

214.

Sullivan PB. Nutritional management of acute diarrhea. Nutrition. 1998;14:758–62.PubMed

215.

Choi EY, Park DA, Park J. Calorie Intake of Enteral Nutrition and Clinical Outcomes in Acutely Critically Ill Patients: A Meta-Analysis of Randomized Controlled Trials. JPEN J Parenter Enteral Nutr. 2014 Jul 30. [Epub ahead of print]

216.

Gerding DN. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129:1012–9.PubMed

217.

Bliss DZ, Johnson S, Savik K, Clabots CL, Willard K, Gerding DN. Acquisition of C. difficile and C. diff-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129:1012–9.PubMed

218.

O’Keefe SJ. A guide to enteral access procedures and enteral nutrition. Nat Rev Gastroenterol Hepatol. 2009;6:207–15.PubMed

219.

O’Keefe SJ. Tube feeding, the microbiota, and Clostridium difficile infection. World J Gastroenterol. 2010;16(2):139–42.PubMedCentralPubMed

220.

Puri BK, Hakkarainen-Smith J, Monro JA. The potential use of cholestyramine to reduce the risk of developing Clostridium difficile-associated diarrhoea in patients receiving long-term intravenous ceftriaxone. Med Hypotheses. 2015;84:78–80.PubMed

221.

Westh H, Iversen JT, Gyrtrup HJ. Clostridium difficile in faecal flora after perioperative prophylaxis with ampicillin or ceftriaxone. J Infect. 1991;23:347–50.PubMed

222.

Olson A, Diebel LN, Liberati DM. Effect of host defenses on Clostridium difficile toxin-induced intestinal carrier injury. J Trauma Acute Care Surg. 2013;74:983–90.PubMed

223.

Diebel LN, Liberati DM. Reinforcement of the intestinal mucus layer protects against Clostridium difficile intestinal injury in vitro. J Am Coll Surg. 2014;219:460–9.PubMed

224.

Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009;48(5):598–605.PubMed

225.

Piacenti FJ, Leuthner KD. Antimicrobial stewardship and Clostridium difficile-associated diarrhea. J Pharm Pract. 2013;26:506–13.PubMed

226.

Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69:1748–54.PubMed

227.

Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4, CD003543.PubMed

228.

Marufu O, Desai N, Aldred D, Brown T, Eltringham I. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003–2011. J Hosp Infect. 2014;89(1):38–45.PubMed

229.

Owens RC. Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2006;26:299–311.PubMed

230.

Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:53–80.PubMed

231.

Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tull P, Gastmeier P, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect. 2008;14:2–20.PubMed

232.

Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis. 2000;31:717–22.PubMed

233.

Willt M, Odenhott I, Walder M. Activity of three disinfectants and acidifi ed nitrate against Clostridium difficile spores. Infect Control Hosp Epidemiol. 2003;24:765–8.

234.

Landelle C, Verachten M, Legrand P, Girou E, Barbut F, Brun-Buisson C. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(1):10–5. doi:10.1086/674396. Epub 2013 Nov 26.PubMed

Title: WSES guidelines for management of Clostridium difficile infection in surgical patients
Authors: Massimo Sartelli
Mark A. Malangoni
Fikri M. Abu-Zidan
Ewen A. Griffiths
Stefano Di Bella
Lynne V. McFarland
Ian Eltringham
Vishal G. Shelat
George C. Velmahos
Ciarán P. Kelly
Sahil Khanna
Zaid M. Abdelsattar
Layan Alrahmani
Luca Ansaloni
Goran Augustin
Miklosh Bala
Frédéric Barbut
Offir Ben-Ishay
Aneel Bhangu
Walter L. Biffl
Stephen M. Brecher
Adrián Camacho-Ortiz
Miguel A. Caínzos
Laura A. Canterbury
Fausto Catena
Shirley Chan
Jill R. Cherry-Bukowiec
Jesse Clanton
Federico Coccolini
Maria Elena Cocuz
Raul Coimbra
Charles H. Cook
Yunfeng Cui
Jacek Czepiel
Koray Das
Zaza Demetrashvili
Isidoro Di Carlo
Salomone Di Saverio
Irina Magdalena Dumitru
Catherine Eckert
Christian Eckmann
Edward H. Eiland
Mushira Abdulaziz Enani
Mario Faro
Paula Ferrada
Joseph Derek Forrester
Gustavo P. Fraga
Jean Louis Frossard
Rita Galeiras
Wagih Ghnnam
Carlos Augusto Gomes
Venkata Gorrepati
Mohamed Hassan Ahmed
Torsten Herzog
Felicia Humphrey
Jae Il Kim
Arda Isik
Rao Ivatury
Yeong Yeh Lee
Paul Juang
Luis Furuya-Kanamori
Aleksandar Karamarkovic
Peter K Kim
Yoram Kluger
Wen Chien Ko
Francis D. LaBarbera
Jae Gil Lee
Ari Leppaniemi
Varut Lohsiriwat
Sanjay Marwah
John E. Mazuski
Gokhan Metan
Ernest E. Moore
Frederick Alan Moore
Carl Erik Nord
Carlos A. Ordoñez
Gerson Alves Pereira Júnior
Nicola Petrosillo
Francisco Portela
Basant K. Puri
Arnab Ray
Mansoor Raza
Miran Rems
Boris E. Sakakushev
Gabriele Sganga
Patrizia Spigaglia
David B. Stewart
Pierre Tattevin
Jean Francois Timsit
Kathleen B. To
Cristian Tranà
Waldemar Uhl
Libor Urbánek
Harry van Goor
Angela Vassallo
Jean Ralph Zahar
Emanuele Caproli
Pierluigi Viale
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: World Journal of Emergency Surgery / Issue 1/2015
Electronic ISSN: 1749-7922
DOI: https://doi.org/10.1186/s13017-015-0033-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

WSES guidelines for management of Clostridium difficile infection in surgical patients

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Etiology, treatment outcome and prognostic factors among patients with secondary peritonitis at Bugando Medical Centre, Mwanza, Tanzania

Severe mutilating injuries with complex macroamputations of the upper extremity – is it worth the effort?

Grading operative findings at laparoscopic cholecystectomy- a new scoring system

Retrospective study of the effectiveness of Intra-Aortic Balloon Occlusion (IABO) for traumatic haemorrhagic shock

Microbial colonization of open abdomen in critically ill surgical patients

Elevated white blood cell count, decreased hematocrit and presence of macrohematuria correlate with abdominal organ injury in pediatric blunt trauma patients: a retrospective study